Pregnancy-dependent growth of mammary tumors is associated with overexpression of insulin-like growth factor II

Cancer Research

Volumn 56, Issue 16, 1996, Pages 3651-3654

  Huynh, Hung ^a   Alpert, Lesley ^a   Pollak, Michael ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; MESSENGER RNA; POLYCLONAL ANTIBODY; RECEPTOR SUBTYPE; SOMATOMEDIN B; SOMATOMEDIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOPSY; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; NORTHERN BLOTTING; PREGNANCY; PRIORITY JOURNAL; RAT; RNA ANALYSIS; TISSUE SECTION; TUMOR VOLUME;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CELL DIVISION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MAMMARY NEOPLASMS, EXPERIMENTAL; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; RATS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0029784068     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. LeRoith, D., Clemmons, D , Nissley, P., and Rechler, M. M. NIH conference Insulin-like growth factors in health and disease Ann Intern Med., 116: 854-862, 1992
2. Resnicoff, M., Abraham, D., Yutanawiboonchai, W., Rotman, H. L., Kajstura, J., Rubin, R , Zoltick, P , and Baserga, R. The insuhn-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55: 2463-2469, 1995
3. Baserga, R. The insulin-like growth factor 1 receptor: a key to tumor growth? Cancer Res. 55 249-252, 1995.
4. Sell, C., Rubini, M., Rubin, R., Liu, J. P., Efstratiadis, A., and Baserga, R. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor Proc. Natl. Acad. Sci. USA, 90: 11217-11221, 1993.
5. Cullen, K. J., Yee, D., Sly, W. S., Perdue, J., Hampton, B., Lippman, M. E., and Rosen, N. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res., 50: 48-53, 1990.
6. Osborne, C K., Coronado, E. B., Kitten, L. J , Arteaga, C. L., Fuqua, S. A , Ramasharma, K., Marshall, M., and Li, C. H. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor Mol Endocrinol, 3: 1701-1709, 1989.
7. Weber, M. M., Melmed, S., Rosenbloom, J , Yamasaki, H., and Prager, D. Rat somatotroph insulin-like growth factor-II (IGF-II) signaling role of the IGF-I receptor Endocrinology, 131, 2147-2153, 1992.
8. Minniti, C. P., Tsokos, M., Newton, W. A., Jr , and Helman, L. J Specific expression of insulin-like growth factor-II in rhabdomyosarcoma tumor cells. Am. J. Clin. Pathol., 101: 198-203, 1994.
9. Gloudemans, T., Prinsen, I., Van Unnik, J. A., Lips, C. J , Den Otter, W , and Sussenbach, J. S. Insulin-like growth factor gene expression in human smooth muscle tumors. Cancer Res , 50: 6689-6695, 1990
10. Reeve, A. E , Eccles, M R , Wilkins, R. J., Bell, G I., and Millow, L J. Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature (Lond.), 317: 258-262, 1992.
11. Florentino, M , Grigioni, W. F., Baccarini, P., D'Errico, A., De Mitri, M S , Pisi, E., and Mancini, A. M. Different in situ expression of insulin-like growth factor type II in hepatocellular carcinoma. An in situ hybridization and immunohistochemical study Diagn Mol Pathol., 3: 59-65, 1994
12. Tricoli, J. V., Rall, L. B , Karakousis, C. P., Herrera, L , Petrelli, N. J., Bell, G. L., and Shows, T. B. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res., 46: 6169-6173, 1986.
13. El-Badry, O. M., Romanus, J. A., Helman, L J., Cooper, M. J , Rechler, M. M , and Israel, M. A. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J. Clin Invest., 84: 829-839, 1989.
14. Haselbacher, G. K , Irminger, J. C., Zapf, J , Ziegler, W. H , and Humbel, R. E. Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein level Proc. Natl Acad. Sci USA, 84: 1104-1106, 1987.
15. Lahm, H , Amstad, P., Wyniger, J., Yilmaz, A., Fischer, J. R., Schreyer, M , and Givel, J. C. Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: evidence of a functional IGF-II-mediated autocrine loop. Int J. Cancer. 58: 452-459, 1994.
16. Paik, S. Expression on IGF-I and IGF-II mRNA in breast tissue. Breast Cancer Res. Treat., 22, 31-38, 1992
17. Manni, A., Badger, B , Wei, L., Zaenglein, A., Grove, R., Khin, S , Heitjan, D , Shimasaki, S., and Ling, N. Hormonal regulation of insulin-like growth factor II and insulin-like growth factor binding protein expression by breast cancer cells in vivo: evidence for stromal epithelial interactions. Cancer Res., 54: 2934-2942, 1994
18. Daughaday, W H. The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors (Review) Endocrinology, 127: 1-4, 1990.
19. Nielsen, F. C., Haselbacher, G., Christiansen, J., Lake, M., Gronborg, M., and Gammeltoft, S. Biosynthesis of 10 kDa and 7.5 kDa insulin-like growth factor II in a human rhabdomyosarcoma cell line Mol. Cell. Endocrinol., 93: 87-95, 1993.
20. Brunner, N., Yee, D., Kern, F. G., Spang-Thomsen, M., Lippman, M. E., and Cullen, K. J Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II). Eur J Cancer. 29a: 562-569, 1993
21. Ogawa, O., Eccles, M. R., Szeto, J., McNoe, L A., Yun, K , Maw, M A., Smith, P. J , and Reeve, A. E. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature (Lond.), 362, 749-751, 1993.
22. Rainier, S., Johnson, L. A., Dobry, C. J , Ping, A. J., Grundy, P. E., and Feinberg, A. P. Relaxation of imprinted genes in human cancer. Nature (Lond.), 362: 747-749, 1993
23. Daly, R. J., Harris, W. H , Wang, D. Y., and Darbre, P. D. Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells. Cell Growth & Differ., 2, 457-464, 1992.
24. Cullen, K. J , Lippman, M. E., Chow, D., Hill, S., Rosen, N., and Zwiebel, J A. Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. Mol. Endocrinol , 6: 91-100, 1992
25. Rogler, C. E., Yang, D , Rossetti, L., Donohoe, J , Alt, E., Chang, C. J., Rosenfeld, R., Neely, K , and Hintz, R. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J. Biol. Chem., 269: 13779-13784, 1994.
26. Huynh, H T., Larsson, C., Narod, S., and Pollak, M. Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor. Cancer Res., 55: 2225-2231, 1995
27. Welsch, C. W. Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res , 45 3415-3443, 1985.
28. Yang, X , Beamer, W., Huynh, H. T., and Pollak, M Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation. Cancer Res., 56; 1509-1511, 1996.
29. Huynh, H T , Tetenes, E , Willace, L., and Pollak, M. In vivo inhibition of insulin-like growth factor-I gene expression by tamoxifen. Cancer Res., 53: 1727-1730, 1993.
30. Bandyopadhyay, G K , Imagawa, W , Wallace, D , and Nandi, S Linoleate metabolites enhance the in vitro proliferative response of mouse mammary epithelial cells to epidermal growth factor J Biol Chem., 262 2750-2756, 1987.
31. Huynh, H. T , Yang, X., and Pollak, M. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J Biol. Chem., 271: 1016-1021, 1996
32. Daughaday, W. H., and Rotwein, P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations Endocr. Rev., 10: 68-89, 1989.
33. Russo, J., and Russo, I. H. Hormonally induced differentiation: a novel approach to breast cancer prevention (Review). J Cell. Biochem. Suppl , 22: 58-64, 1995.
34. Leon, D. A., Carpenter, L. M , Broeders, M J , Gunnarskog, J., and Murphy, M. F. Breast cancer in Swedish women before age 50: evidence of a dual effect of completed pregnancy. Cancer Causes Control. 6: 283-291, 1995.
35. Guinee, V. F., Olsson, H., Moller, T., Hess, K. R., Taylor, S. H , Fahey, T., Gladikov, J. V van den Blink, J. W., Bonichon, F., Dische, S., et al Effect of pregnancy on prognosis for young women with breast cancer. Lancet, 343: 1587-1589, 1994.
36. Marchant, D J Breast cancer in pregnancy. Clin Obstet. Gynaecol., 37, 993-997, 1994.